Challenges of Connecting Chemistry to Pharmacology: Perspectives from Curating the IUPHAR/BPS Guide to PHARMACOLOGY
暂无分享,去创建一个
Adam J. Pawson | Jamie A. Davies | Elena Faccenda | Adam J Pawson | Joanna L. Sharman | Christopher Southan | Simon D. Harding | C. Southan | J. Davies | E. Faccenda | S. Harding | J. Sharman
[1] Masters,et al. Cell line misidentification: the beginning of the end , 2010 .
[2] Alasdair J. G. Gray,et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY , 2017, Nucleic Acids Res..
[3] American Type Culture Collection Standards Development Orga ASN-0002. Cell line misidentification: the beginning of the end , 2010, Nature Reviews Cancer.
[4] Peter Murray-Rust,et al. Minimum information about a bioactive entity (MIABE) , 2011, Nature Reviews Drug Discovery.
[5] Antony J. Williams,et al. Dispensing Processes Impact Apparent Biological Activity as Determined by Computational and Statistical Analyses , 2013, PloS one.
[6] Christopher Southan,et al. SynPharm: A Guide to PHARMACOLOGY Database Tool for Designing Drug Control into Engineered Proteins , 2018, ACS omega.
[7] Qin Jiang,et al. Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease. , 2016, Journal of medicinal chemistry.
[8] Henning Hermjakob,et al. Shared resources, shared costs—leveraging biocuration resources , 2015, Database J. Biol. Databases Curation.
[9] Christopher Southan,et al. Extracting and connecting chemical structures from text sources using chemicalize.org , 2013, Journal of Cheminformatics.
[10] Tony Taldone,et al. Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. , 2008, Bioorganic & medicinal chemistry letters.
[11] Sean Ekins,et al. Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates. , 2013, Drug discovery today.
[12] Yanli Wang,et al. PubChem BioAssay: A Decade’s Development toward Open High-Throughput Screening Data Sharing , 2017, SLAS discovery : advancing life sciences R & D.
[13] Michael K Gilson,et al. Digital chemistry in the Journal of Medicinal Chemistry. , 2014, Journal of medicinal chemistry.
[14] Adam J Pawson,et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands , 2013, Pharmacological Reviews.
[15] Susan Tweedie,et al. Genenames.org: the HGNC and VGNC resources in 2017 , 2016, Nucleic Acids Res..
[16] Lawrence Mbuagbaw,et al. Exploring the characteristics, global distribution and reasons for retraction of published articles involving human research participants: a literature survey , 2018, Journal of multidisciplinary healthcare.
[17] M. Baker. Reproducibility crisis: Blame it on the antibodies , 2015, Nature.
[18] Antony J. Williams,et al. Machines first, humans second: on the importance of algorithmic interpretation of open chemistry data , 2015, Journal of Cheminformatics.
[19] A. Churg,et al. AZD9668: Pharmacological Characterization of a Novel Oral Inhibitor of Neutrophil Elastase , 2011, Journal of Pharmacology and Experimental Therapeutics.
[20] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[21] Jörg B Schulz,et al. The impact of fraudulent and irreproducible data to the translational research crisis – solutions and implementation , 2016, Journal of neurochemistry.
[22] Antony J. Williams,et al. Ambiguity of non-systematic chemical identifiers within and between small-molecule databases , 2015, Journal of Cheminformatics.
[23] Wilhelm Huisinga,et al. Mechanism-Based Inhibition: Deriving KI and kinact Directly from Time-Dependent IC50 Values , 2009, Journal of biomolecular screening.
[24] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[25] Paul A Insel,et al. Experimental design and analysis and their reporting: new guidance for publication in BJP , 2015, British journal of pharmacology.
[26] Robert L. Perlman,et al. Mouse models of human disease evolutionary perspective , 2016 .
[27] A. Valencia,et al. Information Retrieval and Text Mining Technologies for Chemistry. , 2017, Chemical reviews.
[28] M. Noor,et al. Data Sharing: How Much Doesn't Get Submitted to GenBank? , 2006, PLoS biology.
[29] David S. Wishart,et al. HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..
[30] Asher Mullard,et al. Reliability of 'new drug target' claims called into question , 2011, Nature Reviews Drug Discovery.
[31] R. Perlman,et al. Mouse models of human disease , 2016, Evolution, medicine, and public health.
[32] Martin Jones,et al. IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels , 2008, Nucleic Acids Res..
[33] George Papadatos,et al. SureChEMBL: a large-scale, chemically annotated patent document database , 2015, Nucleic Acids Res..
[34] Evan Bolton,et al. Database resources of the National Center for Biotechnology Information , 2017, Nucleic Acids Res..
[35] Igor V. Filippov,et al. Optical Structure Recognition Software To Recover Chemical Information: OSRA, An Open Source Solution , 2009, J. Chem. Inf. Model..
[36] Biocuration: Distilling data into knowledge , 2018, PLoS biology.
[37] Ubbo Visser,et al. Fast and accurate semantic annotation of bioassays exploiting a hybrid of machine learning and user confirmation , 2014, PeerJ.
[38] Gregory D. Schuler,et al. Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.
[39] Sorel Muresan,et al. Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds , 2011, J. Cheminformatics.
[40] Declan Butler,et al. Scientists in the dark after French clinical trial proves fatal , 2016, Nature.
[41] John P. Overington,et al. Chemical databases: curation or integration by user-defined equivalence? , 2015, Drug discovery today. Technologies.
[42] Joanna L. Sharman,et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands , 2015, Nucleic Acids Res..
[43] Christopher Southan,et al. Caveat Usor: Assessing Differences between Major Chemistry Databases , 2018, ChemMedChem.
[44] Ali Nahvi,et al. Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry. , 2018, ACS chemical biology.
[45] O. Witte,et al. Sphingosylphosphorylcholine and Lysophosphatidylcholine Are Ligands for the G Protein-coupled Receptor GPR4* , 2001, The Journal of Biological Chemistry.
[46] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[47] Jacob K. Asiedu,et al. The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.
[48] Peter Murray-Rust,et al. Chemical Name to Structure: OPSIN, an Open Source Solution , 2011, J. Chem. Inf. Model..
[49] Ben Goldacre,et al. Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study , 2017, British Medical Journal.
[50] Christopher Southan,et al. Expanding opportunities for mining bioactive chemistry from patents , 2015, Drug discovery today. Technologies.
[51] Arthur Christopoulos,et al. A kinetic view of GPCR allostery and biased agonism. , 2017, Nature chemical biology.
[52] Lucia Gardossi,et al. Guidelines for reporting of biocatalytic reactions. , 2010, Trends in biotechnology.